Dian Wang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.
Journal: Frontiers in oncology
Published: February 27, 2026
Real-world data from patients with gastric-type mucinous carcinoma of the cervix: a multicenter, retrospective study.
Journal: Future oncology (London, England)
Published: February 03, 2025
Neuroendocrine carcinoma of the cervix (NECC): A retrospective study of 175 Chinese patients.
Journal: European journal of obstetrics & gynecology and reproductive biology: X
Published: January 08, 2025
Immunotherapy benefits PD‑L1‑positive gastric‑type endocervical adenocarcinoma: A multicenter, retrospective study.
Journal: Molecular and clinical oncology
Published: December 14, 2024
Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent/metastatic cervical cancer treated with PD-1/PD-L1 inhibitors.
Journal: Discover oncology
Published: November 23, 2024
The efficacy of anti-angiogenic drugs in gastric-type endocervical adenocarcinoma: A retrospective study.
Journal: The journal of obstetrics and gynaecology research
Published: September 28, 2024
The Contribution and Perspectives of Proteomics to Epithelial Ovarian Cancer.
Journal: Proteomics. Clinical applications
Published: July 22, 2024
Efficacy of PD-1/PD-L1 blockade immunotherapy in recurrent/metastatic high-grade neuroendocrine carcinoma of the cervix: A retrospective study.
Journal: Heliyon
Published: March 04, 2024
Integrating MRI-based radiomics and clinicopathological features for preoperative prognostication of early-stage cervical adenocarcinoma patients: in comparison to deep learning approach.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 05, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026